• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Maintaining osteoclastogenesis following allogeneic hematopoietic stem cell transplantation for osteopetrosis: evidence from testing.

作者信息

Savaşan Süreyya, Gadgeel Manisha, Freeman Cathryn, Moussa Omar

机构信息

Children's Hospital of Michigan, Division of Hematology/Oncology, Pediatric Blood and Marrow Transplant Program, Barbara Ann Karmanos Cancer Center, Detroit, MI, USA; Central Michigan University College of Medicine, Department of Pediatrics, Mount Pleasant, MI, USA; Children's Hospital of Michigan, Division of Hematology/Oncology, Hematology/Oncology Flow Cytometry Laboratory, Detroit, MI.

Children's Hospital of Michigan, Division of Hematology/Oncology, Hematology/Oncology Flow Cytometry Laboratory, Detroit, MI.

出版信息

Haematologica. 2022 Nov 1;107(11):2760-2764. doi: 10.3324/haematol.2022.280895.

DOI:10.3324/haematol.2022.280895
PMID:35796009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9614523/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ba4/9614523/63720b5514bd/1072760.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ba4/9614523/85e6ea34325d/1072760.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ba4/9614523/63720b5514bd/1072760.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ba4/9614523/85e6ea34325d/1072760.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ba4/9614523/63720b5514bd/1072760.fig2.jpg

相似文献

1
Maintaining osteoclastogenesis following allogeneic hematopoietic stem cell transplantation for osteopetrosis: evidence from testing.异基因造血干细胞移植治疗骨硬化症后破骨细胞生成的维持：来自检测的证据。
Haematologica. 2022 Nov 1;107(11):2760-2764. doi: 10.3324/haematol.2022.280895.
2
Comparison of Optic Canal Diameter in Children With Malignant Infantile Osteopetrosis and Normal Children and the Effects of Hematopoietic Stem Cell Transplantation on the Optic Canal Diameter.恶性婴儿型骨硬化症患儿与正常儿童视神经管直径的比较及造血干细胞移植对视神经管直径的影响
J Pediatr Ophthalmol Strabismus. 2019 Jan 23;56(1):35-42. doi: 10.3928/01913913-20180921-01. Epub 2018 Oct 26.
3
Skeletal Changes After Hematopoietic Stem Cell Transplantation in Osteopetrosis.成骨不全症患者造血干细胞移植后的骨骼变化。
J Bone Miner Res. 2020 Sep;35(9):1645-1651. doi: 10.1002/jbmr.4037. Epub 2020 Jul 12.
4
Hematopoietic stem cell transplantation in a patient with osteopetrosis and mutation in CLCN7: long-term follow-up.成骨不全症和 CLCN7 基因突变患者的造血干细胞移植：长期随访。
Bol Med Hosp Infant Mex. 2021 Mar 2;78(3):225-233. doi: 10.24875/BMHIM.20000105.
5
Hematopoietic stem cell transplantation for infantile osteopetrosis.婴儿骨硬化症的造血干细胞移植
Bone Marrow Transplant. 1998 Nov;22(10):941-6. doi: 10.1038/sj.bmt.1701474.
6
Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice.造血干细胞靶向新生儿基因治疗逆转了 oc/oc 小鼠致命性进行性骨硬化症。
Blood. 2007 Jun 15;109(12):5178-85. doi: 10.1182/blood-2006-12-061382. Epub 2007 Mar 1.
7
Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in Mice.利用临床适用的慢病毒载体对造血干细胞进行靶向性新生儿基因治疗可纠正小鼠的骨质石化症。
Hum Gene Ther. 2019 Nov;30(11):1395-1404. doi: 10.1089/hum.2019.047. Epub 2019 Jul 3.
8
Hematopoietic stem cell transplantation for osteopetrosis.造血干细胞移植治疗成骨不全症。
Pediatr Clin North Am. 2010 Feb;57(1):171-80. doi: 10.1016/j.pcl.2009.11.006.
9
[Visual function of seven children with malignant osteopetrosis after hematopoietic stem cell transplantation].[7例恶性骨硬化症患儿造血干细胞移植后的视觉功能]
Zhonghua Yan Ke Za Zhi. 2013 Jun;49(6):541-6.
10
[Allogeneic stem cell transplantation for 8 patients with malignant infantile osteopetrosis in China].[中国8例恶性婴儿骨硬化症患者的异基因干细胞移植]
Zhonghua Er Ke Za Zhi. 2012 Nov;50(11):807-12.

本文引用的文献

1
How we approach malignant infantile osteopetrosis.我们如何治疗婴儿恶性成骨性骨硬化症。
Pediatr Blood Cancer. 2021 Mar;68(3):e28841. doi: 10.1002/pbc.28841. Epub 2020 Dec 12.
2
An infant with severe combined immunodeficiency, osteopetrosis, chromosomally integrated herpesvirus-6 infection, and hemophagocytic syndrome: What are the links?一名患有严重联合免疫缺陷、骨质石化症、染色体整合型疱疹病毒6感染及噬血细胞综合征的婴儿：其间有何关联？
Pediatr Blood Cancer. 2021 Jan;68(1):e28564. doi: 10.1002/pbc.28564. Epub 2020 Aug 18.
3
Inherited chromosomally integrated human herpesvirus-6 in a patient with XIAP deficiency.
患者 XIAP 缺陷中存在遗传性染色体整合人疱疹病毒 6。
Transpl Infect Dis. 2020 Oct;22(5):e13331. doi: 10.1111/tid.13331. Epub 2020 Jun 8.
4
Developmental origin, functional maintenance and genetic rescue of osteoclasts.破骨细胞的发育起源、功能维持和遗传修复。
Nature. 2019 Apr;568(7753):541-545. doi: 10.1038/s41586-019-1105-7. Epub 2019 Apr 10.
5
One Disease, Many Genes: Implications for the Treatment of Osteopetroses.一种疾病，多个基因：对骨硬化症治疗的启示
Front Endocrinol (Lausanne). 2019 Feb 19;10:85. doi: 10.3389/fendo.2019.00085. eCollection 2019.
6
Osteoclasts secrete osteopontin into resorption lacunae during bone resorption.破骨细胞在骨吸收过程中将骨桥蛋白分泌到吸收陷窝中。
Histochem Cell Biol. 2019 Jun;151(6):475-487. doi: 10.1007/s00418-019-01770-y. Epub 2019 Jan 14.
7
Peripheral blood monocytes show increased osteoclast differentiation potential compared to bone marrow monocytes.与骨髓单核细胞相比，外周血单核细胞表现出更高的破骨细胞分化潜能。
Heliyon. 2018 Sep 12;4(9):e00780. doi: 10.1016/j.heliyon.2018.e00780. eCollection 2018 Sep.
8
An Optimized Method to Generate Human Active Osteoclasts From Peripheral Blood Monocytes.从外周血单核细胞中生成人活性破骨细胞的优化方法。
Front Immunol. 2018 Apr 4;9:632. doi: 10.3389/fimmu.2018.00632. eCollection 2018.
9
Radiologic resolution of malignant infantile osteopetrosis skeletal changes following hematopoietic stem cell transplantation.
Pediatr Blood Cancer. 2015 Sep;62(9):1645-9. doi: 10.1002/pbc.25524. Epub 2015 Mar 27.
10
Immunohistochemical identification of osteoclasts and multinucleated macrophages.破骨细胞和多核巨噬细胞的免疫组织化学鉴定
Cell Immunol. 2014 Nov-Dec;292(1-2):53-6. doi: 10.1016/j.cellimm.2014.09.002. Epub 2014 Sep 28.